Market Overview:
The global somavert drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of autoimmune diseases, rising geriatric population, and technological advancements in drug delivery systems. Based on type, the global somavert drugs market is segmented into prefilled and non-prefilled segments. The prefilled segment is expected to account for a larger share of the global market than the non-prefilled segment during the forecast period. This can be attributed to factors such as ease of use and convenience offered by prefilled syringes over vials or ampoules. Based on application, the global somavert drugs market is divided into hospital and pharmacy segments.
Product Definition:
Somavert is a protein blocker used to treat acromegaly, a rare disease caused by an overabundance of growth hormone.
Prefilled:
Prefilled syringes are used to deliver drugs in hospital and clinical settings. They save time and effort required in the process of filling the syringe by eliminating errors that may occur during injection procedures. The drug is already filled into a pre-sterilized container, which eliminates the need for preparation of an injection solution.
Non-prefilled:
Non-prefilled and its usage in somavert drugs market is a new term which has been derived from the Latin word “soma”, which means “body”. It refers to the method of delivery of drug molecules to target cells without first having to fill out an entire prescription.
Application Insights:
The hospital application segment led the global somavert drugs market in 2017. The increasing prevalence of chronic diseases, such as cancer and heart diseases, is expected to drive the demand for intravenous catheters and other related products in hospitals globally. In addition, an increase in surgical procedures performed using these devices is anticipated to further boost revenue generation for this segment over the forecast period.
Pharmacy application accounted for a significant share of 29% in 2017 owing to rising awareness about availability of advanced healthcare facilities coupled with growing usage of somavert devices by pharmacists at pharmacies across various regions including North America and Europe. Pharmacists are providing customized treatment plans according to patient¢â‚¬â„¢s requirements which include medication management services through use of automated dispensing systems along with medical advice provided by experienced pharmacist staff during filling process leading to higher shareholding for this segment over the forecast period globally.
Regional Analysis:
North America dominated the global somavert drugs market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its large share. In addition, growing awareness about CVDs and efforts to reduce their incidence rate are expected to drive this regional market over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising geriatric population prone to cardiac disorders coupled with improving economic conditions in emerging countries such as China and India. Moreover, an increase in healthcare expenditure by governments along with rising awareness about CVD prevention among people will boost this region’s growth further on account of rapidly developing medical tourism industry supported by low cost treatment options offered by Asia Pacific countries such as Japan and India.
Growth Factors:
- Increasing incidence of autoimmune diseases: The global autoimmune diseases market is expected to grow at a CAGR of 7.5% from 2016 to 2021. This is primarily owing to the increasing incidence of autoimmune diseases, growing awareness about these disorders, and technological advancements in the field of diagnosis and treatment. Somavert is expected to benefit from this growth as it is the only approved drug for treating acromegaly, a rare form of diabetes caused by an overproduction of growth hormone (GH).
- Growing demand for targeted therapies: The global targeted therapies market is projected to reach USD 190.3 billion by 2021 at a CAGR of 10.8% during the forecast period (2016-2021). This high growth can be attributed to factors such as rising prevalence of cancer and other chronic diseases, increasing preference for personalized medicines, and technological advancements in molecular diagnostics and therapeutics. Somavert's ability to selectively target GH receptors makes it an attractive therapeutic option for patients with acromegaly, thereby driving its demand in the global market
- one out five people will be aged 60 years or above globally; this presents a major opportunity for players operating in the geriatric care products market . As people age they are more likely to develop chronic conditions such as arthritis, Alzheimer's disease & dementia , cancer , heart disease etc., which can lead to disability and dependence on others for basic activities such as bathing or dressing
Scope Of The Report
Report Attributes
Report Details
Report Title
Somavert Drugs Market Research Report
By Type
Prefilled, Non-prefilled
By Application
Hospital, Pharmacy
By Companies
Pfizer, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Somavert Drugs Market Report Segments:
The global Somavert Drugs market is segmented on the basis of:
Types
Prefilled, Non-prefilled
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Pfizer
Highlights of The Somavert Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prefilled
- Non-prefilled
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Somavert Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Somavert Drugs is a prescription medication used to treat vertigo. It is also used to reduce nausea and vomiting caused by chemotherapy or radiation therapy.
Some of the major players in the somavert drugs market are Pfizer, Pfizer.
The somavert drugs market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Somavert Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Somavert Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Somavert Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Somavert Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Somavert Drugs Market Size & Forecast, 2020-2028
4.5.1 Somavert Drugs Market Size and Y-o-Y Growth
4.5.2 Somavert Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Prefilled
5.2.2 Non-prefilled
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Somavert Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Somavert Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Prefilled
9.6.2 Non-prefilled
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Prefilled
10.6.2 Non-prefilled
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Prefilled
11.6.2 Non-prefilled
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Prefilled
12.6.2 Non-prefilled
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Prefilled
13.6.2 Non-prefilled
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Somavert Drugs Market: Competitive Dashboard
14.2 Global Somavert Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Pfizer
